MORGAN STANLEY - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 100 filers reported holding DESIGN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$850,208
-29.3%
360,258
+88.8%
0.00%
Q2 2023$1,201,839
+200.2%
190,768
+175.0%
0.00%
Q1 2023$400,305
-5.8%
69,377
+67.5%
0.00%
Q4 2022$425,010
-56.9%
41,424
-29.7%
0.00%
Q3 2022$985,000
+81.1%
58,935
+51.8%
0.00%
Q2 2022$544,000
+162.8%
38,832
+203.0%
0.00%
Q1 2022$207,000
-27.4%
12,816
-3.7%
0.00%
Q4 2021$285,000
+163.9%
13,304
+79.7%
0.00%
Q3 2021$108,000
+730.8%
7,404
+1044.4%
0.00%
Q2 2021$13,0006470.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,526,476$15,402,4837.89%
Logos Global Management LP 5,032,501$11,876,7021.58%
Prosight Management, LP 1,203,745$2,840,8380.90%
TANG CAPITAL MANAGEMENT LLC 1,350,000$3,186,0000.45%
Soleus Capital Management, L.P. 1,025,000$2,419,0000.22%
RTW INVESTMENTS, LP 2,512,986$5,930,6470.12%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 180,000$425,0000.09%
Corton Capital Inc. 27,134$64,0360.03%
OCCUDO QUANTITATIVE STRATEGIES LP 100,722$237,7040.03%
Rock Springs Capital Management LP 460,391$1,086,5230.03%
View complete list of DESIGN THERAPEUTICS INC shareholders